A healthcare chatbot can be a patient’s first point of contact for some sensitive conversations from mental health to billing, a new CU Anschutz study has found.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Q2 2023 Revenue increased 22% to $45.0 Million; EPS $0.09 ENGLEWOOD, Colo., July 27, 2023 /PRNewswire/ — Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical […]
ENGLEWOOD, Colo., Oct. 16, 2024 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold […]
BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the large multi-center observational registry study INSIGHT (Clinical Effectiveness Assessment of VeriStrat® […]
Copyright © 2026 Biotech Networks
